132 related articles for article (PubMed ID: 38043136)
1. Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation.
Kwan K; Castro-Sandoval O; Ma B; Martelino D; Saffari A; Liu XL; Orvain C; Mellitzer G; Gaiddon C; Storr T
J Inorg Biochem; 2024 Feb; 251():112433. PubMed ID: 38043136
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C.
Miller JJ; Kwan K; Blanchet A; Orvain C; Mellitzer G; Smith J; Lento C; Nouchikian L; Omoregbee-Leichnitz S; Sabatou M; Wilson D; Gaiddon C; Storr T
J Inorg Biochem; 2023 May; 242():112164. PubMed ID: 36871418
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.
Zaman S; Yu X; Bencivenga AF; Blanden AR; Liu Y; Withers T; Na B; Blayney AJ; Gilleran J; Boothman DA; Loh SN; Kimball SD; Carpizo DR
Mol Cancer Ther; 2019 Aug; 18(8):1355-1365. PubMed ID: 31196889
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Compounds for Activation of the p53-Y220C Mutant in Cancer.
Miller JJ; Orvain C; Jozi S; Clarke RM; Smith JR; Blanchet A; Gaiddon C; Warren JJ; Storr T
Chemistry; 2018 Dec; 24(67):17734-17742. PubMed ID: 30230059
[TBL] [Abstract][Full Text] [Related]
5. A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.
Miller JJ; Kwan K; Gaiddon C; Storr T
J Biol Inorg Chem; 2022 Aug; 27(4-5):393-403. PubMed ID: 35488931
[TBL] [Abstract][Full Text] [Related]
6. Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53.
Yu X; Blanden A; Tsang AT; Zaman S; Liu Y; Gilleran J; Bencivenga AF; Kimball SD; Loh SN; Carpizo DR
Mol Pharmacol; 2017 Jun; 91(6):567-575. PubMed ID: 28320780
[TBL] [Abstract][Full Text] [Related]
7. Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism.
Yu X; Blanden AR; Narayanan S; Jayakumar L; Lubin D; Augeri D; Kimball SD; Loh SN; Carpizo DR
Oncotarget; 2014 Oct; 5(19):8879-92. PubMed ID: 25294809
[TBL] [Abstract][Full Text] [Related]
8. Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer.
Blanden AR; Yu X; Loh SN; Levine AJ; Carpizo DR
Drug Discov Today; 2015 Nov; 20(11):1391-7. PubMed ID: 26205328
[TBL] [Abstract][Full Text] [Related]
9. Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics.
Kogan S; Carpizo DR
Cancers (Basel); 2018 May; 10(6):. PubMed ID: 29843463
[TBL] [Abstract][Full Text] [Related]
10. Synthetic metallochaperone ZMC1 rescues mutant p53 conformation by transporting zinc into cells as an ionophore.
Blanden AR; Yu X; Wolfe AJ; Gilleran JA; Augeri DJ; O'Dell RS; Olson EC; Kimball SD; Emge TJ; Movileanu L; Carpizo DR; Loh SN
Mol Pharmacol; 2015 May; 87(5):825-31. PubMed ID: 25710967
[TBL] [Abstract][Full Text] [Related]
11. Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics.
Yu X; Kogan S; Chen Y; Tsang AT; Withers T; Lin H; Gilleran J; Buckley B; Moore D; Bertino J; Chan C; Kimball SD; Loh SN; Carpizo DR
Clin Cancer Res; 2018 Sep; 24(18):4505-4517. PubMed ID: 29914895
[No Abstract] [Full Text] [Related]
12. Biological Effects of HDAC Inhibitors Vary with Zinc Binding Group: Differential Effects on Zinc Bioavailability, ROS Production, and R175H p53 Mutant Protein Reactivation.
Flores BM; Uppalapati CK; Pascual AS; Vong A; Baatz MA; Harrison AM; Leyva KJ; Hull EE
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002270
[TBL] [Abstract][Full Text] [Related]
13. Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.
Gilleran JA; Yu X; Blayney AJ; Bencivenga AF; Na B; Augeri DJ; Blanden AR; Kimball SD; Loh SN; Roberge JY; Carpizo DR
J Med Chem; 2021 Feb; 64(4):2024-2045. PubMed ID: 33538587
[TBL] [Abstract][Full Text] [Related]
14. The missing zinc: p53 misfolding and cancer.
Loh SN
Metallomics; 2010 Jul; 2(7):442-9. PubMed ID: 21072344
[TBL] [Abstract][Full Text] [Related]
15. Peptide models of Cu(I) and Zn(II) metallochaperones: the effect of pH on coordination and mechanistic implications.
Shoshan MS; Shalev DE; Tshuva EY
Inorg Chem; 2013 Mar; 52(6):2993-3000. PubMed ID: 23458158
[TBL] [Abstract][Full Text] [Related]
16. The effect of zinc and the role of p53 in copper-induced cellular stress responses.
Formigari A; Gregianin E; Irato P
J Appl Toxicol; 2013 Jul; 33(7):527-36. PubMed ID: 23401182
[TBL] [Abstract][Full Text] [Related]
17. Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.
Blanden AR; Yu X; Blayney AJ; Demas C; Ha JH; Liu Y; Withers T; Carpizo DR; Loh SN
Elife; 2020 Dec; 9():. PubMed ID: 33263541
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Insights into the Metal-Dependent Activation of Zn
Jordan MR; Wang J; Weiss A; Skaar EP; Capdevila DA; Giedroc DP
Inorg Chem; 2019 Oct; 58(20):13661-13672. PubMed ID: 31247880
[TBL] [Abstract][Full Text] [Related]
19. Crystal Structure of the Human Copper Chaperone ATOX1 Bound to Zinc Ion.
Mangini V; Belviso BD; Nardella MI; Natile G; Arnesano F; Caliandro R
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291703
[TBL] [Abstract][Full Text] [Related]
20. A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells.
Garufi A; Trisciuoglio D; Porru M; Leonetti C; Stoppacciaro A; D'Orazi V; Avantaggiati M; Crispini A; Pucci D; D'Orazi G
J Exp Clin Cancer Res; 2013 Oct; 32(1):72. PubMed ID: 24220325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
